LEVIN ALAN G
Insider CIK 1174452 · RESX Director · ENDP EVP, Chief Financial Officer · ACET Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 79,565 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-06-12 | 2025-06-16 | 27,181 | — | $0 | 27,181 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-06-12 | 2025-06-16 | 12,500 | — | $0 | 64,271 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 51,771 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-30 | 2024-05-31 | 7,861 | $6.36 | $50.0K | 44,951 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 37,090 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-05-31 | 2023-06-02 | 1,360 | $8.27 | $11.2K | 20,345 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-02-28 | 2023-03-02 | 1,271 | $8.85 | $11.2K | 18,985 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-11-30 | 2022-12-02 | 842 | $13.36 | $11.2K | 17,714 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-08-31 | 2022-09-02 | 809 | $13.90 | $11.2K | 16,872 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 16,063 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-05-31 | 2022-06-02 | 1,138 | $9.31 | $10.6K | 3,197 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-02-28 | 2022-03-02 | 602 | $16.61 | $10.0K | 2,059 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-11-30 | 2021-12-02 | 829 | $12.06 | $10.0K | 1,457 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-08-31 | 2021-09-02 | 628 | $15.92 | $10.0K | 628 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2021-07-01 | 2021-07-06 | 83,300 | — | $0 | 83,300 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-05-25 | 2021-05-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-06-17 | 2020-06-18 | 61,300 | — | $0 | 61,300 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-27 | 2020-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACETQ ACETO CORP | J Other | 2019-10-01 | 2019-10-03 | 18,248 | — | $0 | 0 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2019-06-13 | 2019-07-19 | 13,100 | — | $0 | 13,100 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2019-06-13 | 2019-08-06 | 19,200 | — | $0 | 19,200 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2018-06-14 | 2018-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2018-01-02 | 2018-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACET ACETO CORP | A Award | 2017-12-07 | 2017-12-11 | 6,737 | $10.39 | $70.0K | 18,248 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2017-06-15 | 2017-06-16 | 23,900 | — | $0 | 23,900 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2016-12-08 | 2016-12-13 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ACET ACETO CORP | A Award | 2016-12-01 | 2016-12-02 | 3,467 | $20.19 | $70.0K | 11,511 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2016-07-21 | 2016-07-25 | 58,473 | — | $0 | 58,473 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2016-01-08 | 2016-01-12 | 276,140 | — | $0 | 276,140 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2016-01-08 | 2016-01-12 | 365,265 | — | $0 | 365,265 | SEC↗ |
| RESX RestorGenex Corp | A Award | 2016-01-08 | 2016-01-12 | 248,032 | — | $0 | 248,032 | SEC↗ |
| ACET ACETO CORP | A Award | 2015-12-15 | 2015-12-16 | 2,711 | $25.82 | $70.0K | 8,044 | SEC↗ |
| ACET ACETO CORP | A Award | 2014-12-04 | 2014-12-05 | 2,169 | $22.13 | $48.0K | 5,333 | SEC↗ |
| ACET ACETO CORP | P Buy | 2014-05-13 | 2014-05-27 | 1,000 | $18.38 | $18.4K | 3,164 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2013-06-01 | 2013-06-04 | 4,376 | $36.30 | $158.8K | 69,431 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | A Award | 2013-03-08 | 2013-03-15 | 14,683 | — | $0 | 47,728 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | A Award deriv | 2013-02-27 | 2013-03-01 | 24,325 | — | $0 | 24,325 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | A Award | 2013-02-27 | 2013-03-01 | 7,342 | — | $0 | 7,342 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2013-02-26 | 2013-02-28 | 1,726 | $28.09 | $48.5K | 2,444 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2013-02-26 | 2013-02-28 | 1,667 | $28.09 | $46.8K | 2,425 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | M Exercise deriv | 2012-12-31 | 2013-01-03 | 21,349 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2012-12-31 | 2013-01-03 | 14,237 | $25.89 | $368.6K | 35,917 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | M Exercise | 2012-12-31 | 2013-01-03 | 32,023 | — | $0 | 50,154 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | M Exercise deriv | 2012-11-15 | 2012-11-19 | 9,954 | — | $0 | 4,979 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | M Exercise | 2012-11-15 | 2012-11-19 | 9,954 | $20.09 | $200.0K | 18,131 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | P Buy | 2012-06-15 | 2012-06-19 | 3,200 | $29.68 | $95.0K | 3,200 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | F Tax w/h | 2012-06-01 | 2012-06-05 | 4,298 | $31.87 | $137.0K | 6,577 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | F Tax w/h | 2012-02-23 | 2012-02-24 | 1,651 | $34.79 | $57.4K | 2,441 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | A Award deriv | 2012-02-22 | 2012-02-24 | 54,905 | — | $0 | 54,905 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | A Award | 2012-02-22 | 2012-02-24 | 16,677 | — | $0 | 33,045 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | A Award | 2012-02-22 | 2012-02-24 | 16,677 | — | $0 | 28,953 | SEC↗ |